Melanoma Immunotherapy: Overcoming Obstacles to Augment Anti-Tumor Immune Responses

Journals Menu

Follow SCIRP

ISSN Print: 2161-4105
ISSN Online: 2161-4512
www.scirp.org/journal/jcdsa
E-mail: jcdsa@scirp.org

Citations h5-index & Ranking*

"Melanoma Immunotherapy: Overcoming Obstacles to Augment Anti-Tumor Immune Responses"
written by Kristian M. Hargadon,
published by Journal of Cosmetics, Dermatological Sciences and Applications, Vol.3 No.2A, 2013

has been cited by the following article(s):

[1]	Melanoma‐derived factors alter the maturation and activation of differentiated tissue‐resident dendritic cells
	Immunology and cell biology, 2016

[2]	Blocking immunosuppressive factors and taking advantage of the nutrient supply within the tumor microenvironment: Pathways to achieve improved cancer …
	ProQuest Dissertations Publishing, 2016

[3]	Pembrolizumab: a novel antiprogrammed death 1 (PD‐1) monoclonal antibody for treatment of metastatic melanoma
	Journal of Clinical Pharmacy and Therapeutics, 2015

[4]	Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells
	Immunology and cell biology, 2015

Follow SCIRP